Lifecore Biomedical to Attend 43rd Annual J.P. Morgan Healthcare Conference

CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. LFCR ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. This prominent event is set to take place from January 13-16, 2025, in San Francisco, California.

Involvement details for Lifecore at the conference include several key discussions and meetings:

• 43^rd Annual J.P. Morgan Healthcare Conference

  The executives from Lifecore who will participate include Paul Josephs, the chief executive officer, and Ryan Lake, the chief financial officer. They will be engaged in one-on-one meetings with investors and stakeholders during the conference.

  Conference Dates: January 13-16, 2025

  Location: San Francisco, California

About Lifecore Biomedical

Lifecore Biomedical, Inc. LFCR operates as a fully integrated contract development and manufacturing organization (CDMO). The company specializes in the development, fill, and finish procedures for sterile injectable pharmaceutical products, which are packaged in syringes, vials, and cartridges, including those with complex formulations. Having established itself as a leading manufacturer of premium injectable-grade hyaluronic acid, Lifecore boasts over 40 years of expertise in collaborating with both global and emerging biopharmaceutical as well as biotechnology companies. The company supports clients across various therapeutic categories, helping to bring innovative medical solutions to the market.

For further details about Lifecore Biomedical, you can visit their website at www.lifecore.com.

conference, biomedical, healthcare